Hepatitis Monthly

Published by: Kowsar

Annual Registry for Hepatitis C and Hepatitis B is Needed for Predicting the Burden of Hepatocellolar Carcinoma in Iran

Zeinab Fazeli 1 , Mohsen Vahedi 2 , Sara Ashtari 3 and Mohamad Amin Pourhoseingholi 3 , *
Authors Information
1 Proteomics Research Center, Students’ Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Health System Research, Gastroenterology and Liver Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
This article has a relationship commentary-article with this article : Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, november 2011, Tehran, Iran
Article information
  • Hepatitis Monthly: February 2013, 13 (2); e8089
  • Published Online: February 24, 2013
  • Article Type: Letter
  • Received: September 8, 2012
  • Accepted: September 21, 2012
  • DOI: 10.5812/hepatmon.8089

To Cite: Fazeli Z, Vahedi M, Ashtari S, Pourhoseingholi M A. Annual Registry for Hepatitis C and Hepatitis B is Needed for Predicting the Burden of Hepatocellolar Carcinoma in Iran, Hepat Mon. 2013 ;13(2):e8089. doi: 10.5812/hepatmon.8089.

Copyright: Copyright © 2013, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Acknowledgements
Footnotes
References
  • 1. Alavian SM, Jabbari H, Daryani NE, Torabi Nami M. Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, november 2011, Tehran, Iran. Hepat Mon. 2012; 12(7): 423-9
  • 2. Fani A, Fani I, Eshrati B, Samadian P, Fani P, Gorishi Y, et al. screening for hepatocellular carcinoma in chronic carriers of hepatitis B and C in markazi province, iran. Hepat Mon. 2007; 7(3): 149-52
  • 3. Alavian SM, Ahmadzad-Asl M, Lankarani KB, Shahbabaie MA, Bahrami Ahmadi A, Kabir A. Hepatitis C infection in the general population of Iran: a systematic review. Hepat Mon. 2009; 9(3): 211-23
  • 4. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med. 2005; 8(2): 84-90
  • 5. Pourhoseingholi MA, Fazeli Z, Zali MR, Alavian SM. Burden of hepatocellular carcinoma in Iran; Bayesian projection and trend analysis. Asian Pac J Cancer Prev. 2010; 11(4): 859-62[PubMed]
  • 6. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 7. Alavian SM. Hepatitis C infection in Iran; A review article. Iran J Clin Infect Dis. 2009; 4(1): 47-59
  • 8. Mohtasham Amiri Z, Rezvani M, Jafari Shakib R, Jafari Shakib A. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province. East Mediterr Health J. 2007; 13(2): 250-6[PubMed]
  • 9. Mohammad Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol. 2005; 11(26): 4085-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader